Special Spring 2025Preview: Technology + System IntegrationTopics to be covered in this issue: more ➔
Special Summer 2025Preview: Clusters + ManufacturingTopics to be covered in this special feature: more ➔
Special Winter 2024Protein Engineering and ServicesMonoclonal antibodies still dominate the US$417bn biologics market. After decades of development, however, improved antibodies and protein formats with better target selectivity and safety profiles … more ➔
Special Autumn 2024CDMOs & CROsA draft US Biosecure Act being passed by the US House of Representatives and discussed by the US Senate could prohibit US biotech developers from collaborating with Chinese CROs, CDMOs and drug developers … more ➔
Special Summer 2024Euro BioFairs CompassGuide to Life Sciences Events in the second half year of 2024 more ➔
Special Spring 2024Bioprocessing & Precision Fermentatio...The biotech and pharma branch is growing steadily. Many companies have full order books for the next few years and expect growth. This is the basis for new investments in assets and infrastructure. These … more ➔
